Primary Care Clinics in Colebrook, NH Accepting Medicare
6 Primary Care Clinics found. Showing 1 - 6
 Vailas Medical Clinic Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 152 Colby St, Colebrook, NH 03576 Phone: 603-731-5589 |
Robert Soucy Do Llc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9 Pleasant St, Suite 1, Colebrook, NH 03576 Phone: 603-237-4579 Fax: 603-237-4579 |
Monadnock Health Care Llc Family Medicine Medicare: Medicare Enrolled Practice Location: 6 First St, Colebrook, NH 03576 Phone: 603-237-4262 |
North Country Medical And Wellness Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 152 Colby Street, Colebrook, NH 03576 Phone: 603-331-0500 |
Indian Stream Health Center, Inc General Practice Medicare: Medicare Enrolled Practice Location: 141 Corliss Lane, Colebrook, NH 03576 Phone: 603-237-8336 Fax: 603-237-4467 |
Weeks Medical Center Clinic/Center Medicare: Medicare Enrolled Practice Location: 141 Corliss Ln, Colebrook, NH 03576 Phone: 603-237-5899 Fax: 603-237-5868 |
News Archive
N.Y. Times poll finds majority of Americans say taxes will exceed benefits
A majority of Americans say they expect to pay more in federal taxes over their lifetime than they will ever receive in benefits from the government, according to a recent New York Times poll. At the same time, the taxes Americans pay today are not keeping pace with the growing costs of government. Medicare is the program projected to add the most to federal spending over the next decade, likely increasing the government's annual budget deficits. But only one in five Americans surveyed named Medicare as the fastest-growing benefits program.
AKT1 genotype influences risk of psychotic disorders in cannabis users
The ability of cannabis to produce psychosis has long been an important public health concern. This concern is growing in importance as there is emerging data that cannabis exposure during adolescence may increase the risk of developing schizophrenia, a serious psychotic disorder. Further, with the advent of medical marijuana, a new group of people with uncertain psychosis risk may be exposed to cannabis.
Additional results from BLISS-76 Phase 3 trial of BENLYSTA presented at International Congress on SLE
Human Genome Sciences, Inc. today announced the presentation of additional results from BLISS-76, one of two pivotal Phase 3 trials of BENLYSTA (belimumab) in seropositive patients with systemic lupus erythematosus. The additional data will be presented in Vancouver at the 9th International Congress on Systemic Lupus Erythematosus on Friday and Saturday, June 25-26.
New research could help predict acute reactions to psychedelic drugs
As psychedelics gain ground as a potential therapy for mental health disorders, there remains a pressing concern that patients in clinical trials may have adverse effects to the drugs.
EDMA calls for empowering people with diabetes
Type 2 diabetes and its complications are frequently diagnosed too late and the complications are often detected only at the time of diagnosis, concludes the European Parliament in its 2006 Written Declaration on Diabetes.
› Verified 9 days ago